Deakin University
Browse

AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM)

conference contribution
posted on 2019-11-01, 00:00 authored by Mark A Rosenthal, Carmen Balana, Myra E van Linde, Cyrus Sayehli, Walter M Fiedler, Martin Wermke, Christophe Massard, Ingo K Mellinghoff, Mustafa Khasraw, Agnes Ang, Erik Rasmussen, Johannes Kast, Sabine Stienen, Timothy F Cloughesy
AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM)

History

Volume

21

Pagination

283-283

Location

Phoenix, AZ

Start date

2019-11-20

End date

2019-11-24

ISSN

1522-8517

eISSN

1523-5866

Language

English

Publication classification

E3 Extract of paper

Title of proceedings

NEURO-ONCOLOGY

Event

24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

Publisher

OXFORD UNIV PRESS INC